Clinical Research
Total Trials
15
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,621
NCT02557035
An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting
Phase: Phase 3
Role: Collaborator
Start: Oct 31, 2015
Completion: Mar 31, 2016
NCT02517021
A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting
Start: Nov 30, 2015
Completion: Aug 31, 2016
NCT03049189
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Start: Feb 2, 2017
Completion: Nov 30, 2029
NCT02888756
iHIVARNA Clinical Trial in HIV Infected Individuals
Phase: Phase 2
Start: Apr 4, 2017
Completion: Feb 12, 2018
NCT03165734
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Start: Jun 26, 2017
Completion: Jul 30, 2027
NCT04119440
Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS
Phase: Phase 1
Start: Apr 16, 2021
Completion: Nov 6, 2024
NCT04907968
Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
Start: Jun 11, 2021
Completion: Oct 3, 2023
NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Phase: Phase 1/2
Start: Jul 20, 2022
Completion: Mar 31, 2028
NCT06752850
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
Phase: Phase 4
Start: Dec 19, 2024
Completion: Dec 31, 2026
NCT06975319
Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers
Phase: Early Phase 1
Start: Jan 29, 2025
Completion: Jul 30, 2026
NCT06579144
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
Start: Feb 24, 2025
Completion: Oct 28, 2025
NCT06716814
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
Start: Mar 6, 2025
Completion: Mar 31, 2027
NCT06499285
The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW)
Start: May 6, 2025
Completion: May 31, 2032
NCT06940830
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
Start: May 21, 2025
Completion: Dec 31, 2028
NCT06782373
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Start: May 28, 2025
Completion: Aug 31, 2027
Loading map...